APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pain Management Drugs & Devices

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pain Management Drugs & Devices Market Analysis and Forecast 2026-2032

26 December 2025196 pages

Choose your research edition.

Industry ResearchPain Management Drugs & Devices Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Pain Management Drugs & Devices Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Pain Management Drugs & Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pain Management Drugs & Devices Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pain Management Drugs & Devices Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Pain Management Drugs & Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pain Management Drugs & Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pain Management Drugs & Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pain Management Drugs & Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pain Management Drugs & Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pain Management Drugs & Devices include Abbott, Johnson & Johnson, Medtronic Inc., Eli Lilly & Co., Pfizer, Abbvie Inc., Purdue Pharmaceuticals Lp, Novartis International Ag and Hisamitsu Pharmaceutical Co. Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pain Management Drugs & Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pain Management Drugs & Devices, also provides the sales of main regions and countries. Of the upcoming market potential for Pain Management Drugs & Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pain Management Drugs & Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pain Management Drugs & Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pain Management Drugs & Devices sales, projected growth trends, production technology, application and end-user industry.

Pain Management Drugs & Devices Segment by Company

Abbott

Johnson & Johnson

Medtronic Inc.

Eli Lilly & Co.

Pfizer

Abbvie Inc.

Purdue Pharmaceuticals Lp

Novartis International Ag

Hisamitsu Pharmaceutical Co. Inc.

Glaxosmithkline

Endo International

Djo Global Inc.

Astrazeneca Depomed Inc.

Pain Management Drugs & Devices Segment by Type

Pharmaceuticals

Devices

Pain Management Drugs & Devices Segment by Application

Cancer Pain

Obstetrical Pain

Musculoskeletal Pain

Migraine Headache Pain

Burn Pain

Neuropathic Pain

Dental/Facial Pain

Pain Management Drugs & Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain Management Drugs & Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pain Management Drugs & Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain Management Drugs & Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pain Management Drugs & Devices in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pain Management Drugs & Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pain Management Drugs & Devices sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pain Management Drugs & Devices Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Pharmaceuticals Major Manufacturers Table 3. Devices Major Manufacturers Table 4. Global Pain Management Drugs & Devices Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Cancer Pain Major Manufacturers Table 6. Obstetrical Pain Major Manufacturers Table 7. Musculoskeletal Pain Major Manufacturers Table 8. Migraine Headache Pain Major Manufacturers Table 9. Burn Pain Major Manufacturers Table 10. Neuropathic Pain Major Manufacturers Table 11. Dental/Facial Pain Major Manufacturers Table 12. Pain Management Drugs & Devices Industry Trends Table 13. Pain Management Drugs & Devices Industry Drivers Table 14. Pain Management Drugs & Devices Industry Opportunities and Challenges Table 15. Pain Management Drugs & Devices Industry Restraints Table 16. Global Pain Management Drugs & Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Pain Management Drugs & Devices Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Pain Management Drugs & Devices Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Pain Management Drugs & Devices Revenue Market Share by Region (2021-2026) Table 20. Global Pain Management Drugs & Devices Revenue Market Share by Region (2027-2032) Table 21. Global Pain Management Drugs & Devices Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 22. Global Pain Management Drugs & Devices Sales by Region (2021-2026) & (W Units) Table 23. Global Pain Management Drugs & Devices Sales by Region (2027-2032) & (W Units) Table 24. Global Pain Management Drugs & Devices Sales Market Share by Region (2021-2026) Table 25. Global Pain Management Drugs & Devices Sales Market Share by Region (2027-2032) Table 26. Global Pain Management Drugs & Devices Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Pain Management Drugs & Devices Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Pain Management Drugs & Devices Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Pain Management Drugs & Devices Sales Market Share by Manufacturers (2021-2026) Table 30. Global Pain Management Drugs & Devices Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 31. Global Pain Management Drugs & Devices Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Pain Management Drugs & Devices Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Pain Management Drugs & Devices Manufacturers, Product Type & Application Table 34. Global Pain Management Drugs & Devices Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Pain Management Drugs & Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Pain Management Drugs & Devices Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Pain Management Drugs & Devices Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Pain Management Drugs & Devices Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Pain Management Drugs & Devices Revenue Market Share by Type (2021-2026) Table 41. Global Pain Management Drugs & Devices Revenue Market Share by Type (2027-2032) Table 42. Global Pain Management Drugs & Devices Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 43. Global Pain Management Drugs & Devices Sales by Type (2021-2026) & (W Units) Table 44. Global Pain Management Drugs & Devices Sales by Type (2027-2032) & (W Units) Table 45. Global Pain Management Drugs & Devices Sales Market Share by Type (2021-2026) Table 46. Global Pain Management Drugs & Devices Sales Market Share by Type (2027-2032) Table 47. Global Pain Management Drugs & Devices Price by Type (2021-2026) & (US$/Unit) Table 48. Global Pain Management Drugs & Devices Price by Type (2027-2032) & (US$/Unit) Table 49. Global Pain Management Drugs & Devices Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Pain Management Drugs & Devices Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Pain Management Drugs & Devices Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Pain Management Drugs & Devices Revenue Market Share by Application (2021-2026) Table 53. Global Pain Management Drugs & Devices Revenue Market Share by Application (2027-2032) Table 54. Global Pain Management Drugs & Devices Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 55. Global Pain Management Drugs & Devices Sales by Application (2021-2026) & (W Units) Table 56. Global Pain Management Drugs & Devices Sales by Application (2027-2032) & (W Units) Table 57. Global Pain Management Drugs & Devices Sales Market Share by Application (2021-2026) Table 58. Global Pain Management Drugs & Devices Sales Market Share by Application (2027-2032) Table 59. Global Pain Management Drugs & Devices Price by Application (2021-2026) & (US$/Unit) Table 60. Global Pain Management Drugs & Devices Price by Application (2027-2032) & (US$/Unit) Table 61. Abbott Company Information Table 62. Abbott Business Overview Table 63. Abbott Pain Management Drugs & Devices Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Abbott Pain Management Drugs & Devices Product Portfolio Table 65. Abbott Recent Development Table 66. Johnson & Johnson Company Information Table 67. Johnson & Johnson Business Overview Table 68. Johnson & Johnson Pain Management Drugs & Devices Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Johnson & Johnson Pain Management Drugs & Devices Product Portfolio Table 70. Johnson & Johnson Recent Development Table 71. Medtronic Inc. Company Information Table 72. Medtronic Inc. Business Overview Table 73. Medtronic Inc. Pain Management Drugs & Devices Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Medtronic Inc. Pain Management Drugs & Devices Product Portfolio Table 75. Medtronic Inc. Recent Development Table 76. Eli Lilly & Co. Company Information Table 77. Eli Lilly & Co. Business Overview Table 78. Eli Lilly & Co. Pain Management Drugs & Devices Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Eli Lilly & Co. Pain Management Drugs & Devices Product Portfolio Table 80. Eli Lilly & Co. Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer Pain Management Drugs & Devices Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Pfizer Pain Management Drugs & Devices Product Portfolio Table 85. Pfizer Recent Development Table 86. Abbvie Inc. Company Information Table 87. Abbvie Inc. Business Overview Table 88. Abbvie Inc. Pain Management Drugs & Devices Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Abbvie Inc. Pain Management Drugs & Devices Product Portfolio Table 90. Abbvie Inc. Recent Development Table 91. Purdue Pharmaceuticals Lp Company Information Table 92. Purdue Pharmaceuticals Lp Business Overview Table 93. Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Product Portfolio Table 95. Purdue Pharmaceuticals Lp Recent Development Table 96. Novartis International Ag Company Information Table 97. Novartis International Ag Business Overview Table 98. Novartis International Ag Pain Management Drugs & Devices Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Novartis International Ag Pain Management Drugs & Devices Product Portfolio Table 100. Novartis International Ag Recent Development Table 101. Hisamitsu Pharmaceutical Co. Inc. Company Information Table 102. Hisamitsu Pharmaceutical Co. Inc. Business Overview Table 103. Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Product Portfolio Table 105. Hisamitsu Pharmaceutical Co. Inc. Recent Development Table 106. Glaxosmithkline Company Information Table 107. Glaxosmithkline Business Overview Table 108. Glaxosmithkline Pain Management Drugs & Devices Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Glaxosmithkline Pain Management Drugs & Devices Product Portfolio Table 110. Glaxosmithkline Recent Development Table 111. Endo International Company Information Table 112. Endo International Business Overview Table 113. Endo International Pain Management Drugs & Devices Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Endo International Pain Management Drugs & Devices Product Portfolio Table 115. Endo International Recent Development Table 116. Djo Global Inc. Company Information Table 117. Djo Global Inc. Business Overview Table 118. Djo Global Inc. Pain Management Drugs & Devices Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Djo Global Inc. Pain Management Drugs & Devices Product Portfolio Table 120. Djo Global Inc. Recent Development Table 121. Astrazeneca Depomed Inc. Company Information Table 122. Astrazeneca Depomed Inc. Business Overview Table 123. Astrazeneca Depomed Inc. Pain Management Drugs & Devices Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Astrazeneca Depomed Inc. Pain Management Drugs & Devices Product Portfolio Table 125. Astrazeneca Depomed Inc. Recent Development Table 126. North America Pain Management Drugs & Devices Revenue by Type (2021-2026) & (US$ Million) Table 127. North America Pain Management Drugs & Devices Revenue by Type (2027-2032) & (US$ Million) Table 128. North America Pain Management Drugs & Devices Sales by Type (2021-2026) & (W Units) Table 129. North America Pain Management Drugs & Devices Sales by Type (2027-2032) & (W Units) Table 130. North America Pain Management Drugs & Devices Sales Price by Type (2021-2026) & (US$/Unit) Table 131. North America Pain Management Drugs & Devices Sales Price by Type (2027-2032) & (US$/Unit) Table 132. North America Pain Management Drugs & Devices Revenue by Application (2021-2026) & (US$ Million) Table 133. North America Pain Management Drugs & Devices Revenue by Application (2027-2032) & (US$ Million) Table 134. North America Pain Management Drugs & Devices Sales by Application (2021-2026) & (W Units) Table 135. North America Pain Management Drugs & Devices Sales by Application (2027-2032) & (W Units) Table 136. North America Pain Management Drugs & Devices Sales Price by Application (2021-2026) & (US$/Unit) Table 137. North America Pain Management Drugs & Devices Sales Price by Application (2027-2032) & (US$/Unit) Table 138. North America Pain Management Drugs & Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. North America Pain Management Drugs & Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. North America Pain Management Drugs & Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. North America Pain Management Drugs & Devices Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 142. North America Pain Management Drugs & Devices Sales by Country (2021-2026) & (W Units) Table 143. North America Pain Management Drugs & Devices Sales by Country (2027-2032) & (W Units) Table 144. North America Pain Management Drugs & Devices Sales Price by Country (2021-2026) & (US$/Unit) Table 145. North America Pain Management Drugs & Devices Sales Price by Country (2027-2032) & (US$/Unit) Table 146. United States Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 147. Canada Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 148. Mexico Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 149. Europe Pain Management Drugs & Devices Revenue by Type (2021-2026) & (US$ Million) Table 150. Europe Pain Management Drugs & Devices Revenue by Type (2027-2032) & (US$ Million) Table 151. Europe Pain Management Drugs & Devices Sales by Type (2021-2026) & (W Units) Table 152. Europe Pain Management Drugs & Devices Sales by Type (2027-2032) & (W Units) Table 153. Europe Pain Management Drugs & Devices Sales Price by Type (2021-2026) & (US$/Unit) Table 154. Europe Pain Management Drugs & Devices Sales Price by Type (2027-2032) & (US$/Unit) Table 155. Europe Pain Management Drugs & Devices Revenue by Application (2021-2026) & (US$ Million) Table 156. Europe Pain Management Drugs & Devices Revenue by Application (2027-2032) & (US$ Million) Table 157. Europe Pain Management Drugs & Devices Sales by Application (2021-2026) & (W Units) Table 158. Europe Pain Management Drugs & Devices Sales by Application (2027-2032) & (W Units) Table 159. Europe Pain Management Drugs & Devices Sales Price by Application (2021-2026) & (US$/Unit) Table 160. Europe Pain Management Drugs & Devices Sales Price by Application (2027-2032) & (US$/Unit) Table 161. Europe Pain Management Drugs & Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. Europe Pain Management Drugs & Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 163. Europe Pain Management Drugs & Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 164. Europe Pain Management Drugs & Devices Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 165. Europe Pain Management Drugs & Devices Sales by Country (2021-2026) & (W Units) Table 166. Europe Pain Management Drugs & Devices Sales by Country (2027-2032) & (W Units) Table 167. Europe Pain Management Drugs & Devices Sales Price by Country (2021-2026) & (US$/Unit) Table 168. Europe Pain Management Drugs & Devices Sales Price by Country (2027-2032) & (US$/Unit) Table 169. Germany Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 170. France Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 171. U.K. Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 172. Italy Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 173. Russia Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 174. Spain Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 175. Netherlands Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 176. Switzerland Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 177. Sweden Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 178. Poland Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 179. China Pain Management Drugs & Devices Revenue by Type (2021-2026) & (US$ Million) Table 180. China Pain Management Drugs & Devices Revenue by Type (2027-2032) & (US$ Million) Table 181. China Pain Management Drugs & Devices Sales by Type (2021-2026) & (W Units) Table 182. China Pain Management Drugs & Devices Sales by Type (2027-2032) & (W Units) Table 183. China Pain Management Drugs & Devices Sales Price by Type (2021-2026) & (US$/Unit) Table 184. China Pain Management Drugs & Devices Sales Price by Type (2027-2032) & (US$/Unit) Table 185. China Pain Management Drugs & Devices Revenue by Application (2021-2026) & (US$ Million) Table 186. China Pain Management Drugs & Devices Revenue by Application (2027-2032) & (US$ Million) Table 187. China Pain Management Drugs & Devices Sales by Application (2021-2026) & (W Units) Table 188. China Pain Management Drugs & Devices Sales by Application (2027-2032) & (W Units) Table 189. China Pain Management Drugs & Devices Sales Price by Application (2021-2026) & (US$/Unit) Table 190. China Pain Management Drugs & Devices Sales Price by Application (2027-2032) & (US$/Unit) Table 191. Asia Pain Management Drugs & Devices Revenue by Type (2021-2026) & (US$ Million) Table 192. Asia Pain Management Drugs & Devices Revenue by Type (2027-2032) & (US$ Million) Table 193. Asia Pain Management Drugs & Devices Sales by Type (2021-2026) & (W Units) Table 194. Asia Pain Management Drugs & Devices Sales by Type (2027-2032) & (W Units) Table 195. Asia Pain Management Drugs & Devices Sales Price by Type (2021-2026) & (US$/Unit) Table 196. Asia Pain Management Drugs & Devices Sales Price by Type (2027-2032) & (US$/Unit) Table 197. Asia Pain Management Drugs & Devices Revenue by Application (2021-2026) & (US$ Million) Table 198. Asia Pain Management Drugs & Devices Revenue by Application (2027-2032) & (US$ Million) Table 199. Asia Pain Management Drugs & Devices Sales by Application (2021-2026) & (W Units) Table 200. Asia Pain Management Drugs & Devices Sales by Application (2027-2032) & (W Units) Table 201. Asia Pain Management Drugs & Devices Sales Price by Application (2021-2026) & (US$/Unit) Table 202. Asia Pain Management Drugs & Devices Sales Price by Application (2027-2032) & (US$/Unit) Table 203. Asia Pain Management Drugs & Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 204. Asia Pain Management Drugs & Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 205. Asia Pain Management Drugs & Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 206. Asia Pain Management Drugs & Devices Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 207. Asia Pain Management Drugs & Devices Sales by Country (2021-2026) & (W Units) Table 208. Asia Pain Management Drugs & Devices Sales by Country (2027-2032) & (W Units) Table 209. Asia Pain Management Drugs & Devices Sales Price by Country (2021-2026) & (US$/Unit) Table 210. Asia Pain Management Drugs & Devices Sales Price by Country (2027-2032) & (US$/Unit) Table 211. Japan Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 212. South Korea Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 213. India Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 214. Australia Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 215. Taiwan Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 216. Southeast Asia Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 217. SAMEA Pain Management Drugs & Devices Revenue by Type (2021-2026) & (US$ Million) Table 218. SAMEA Pain Management Drugs & Devices Revenue by Type (2027-2032) & (US$ Million) Table 219. SAMEA Pain Management Drugs & Devices Sales by Type (2021-2026) & (W Units) Table 220. SAMEA Pain Management Drugs & Devices Sales by Type (2027-2032) & (W Units) Table 221. SAMEA Pain Management Drugs & Devices Sales Price by Type (2021-2026) & (US$/Unit) Table 222. SAMEA Pain Management Drugs & Devices Sales Price by Type (2027-2032) & (US$/Unit) Table 223. SAMEA Pain Management Drugs & Devices Revenue by Application (2021-2026) & (US$ Million) Table 224. SAMEA Pain Management Drugs & Devices Revenue by Application (2027-2032) & (US$ Million) Table 225. SAMEA Pain Management Drugs & Devices Sales by Application (2021-2026) & (W Units) Table 226. SAMEA Pain Management Drugs & Devices Sales by Application (2027-2032) & (W Units) Table 227. SAMEA Pain Management Drugs & Devices Sales Price by Application (2021-2026) & (US$/Unit) Table 228. SAMEA Pain Management Drugs & Devices Sales Price by Application (2027-2032) & (US$/Unit) Table 229. SAMEA Pain Management Drugs & Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 230. SAMEA Pain Management Drugs & Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 231. SAMEA Pain Management Drugs & Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 232. SAMEA Pain Management Drugs & Devices Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 233. SAMEA Pain Management Drugs & Devices Sales by Country (2021-2026) & (W Units) Table 234. SAMEA Pain Management Drugs & Devices Sales by Country (2027-2032) & (W Units) Table 235. SAMEA Pain Management Drugs & Devices Sales Price by Country (2021-2026) & (US$/Unit) Table 236. SAMEA Pain Management Drugs & Devices Sales Price by Country (2027-2032) & (US$/Unit) Table 237. Brazil Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 238. Argentina Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 239. Chile Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 240. Colombia Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 241. Peru Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 242. Saudi Arabia Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 243. Israel Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 244. UAE Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 245. Turkey Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 246. Iran Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 247. Egypt Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Table 248. Key Raw Materials Table 249. Raw Materials Key Suppliers Table 250. Pain Management Drugs & Devices Distributors List Table 251. Pain Management Drugs & Devices Customers List Table 252. Research Programs/Design for This Report Table 253. Authors List of This Report Table 254. Secondary Sources Table 255. Primary Sources List of Figures Figure 1. Pain Management Drugs & Devices Image Figure 2. Global Pain Management Drugs & Devices Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pain Management Drugs & Devices Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pharmaceuticals Image Figure 5. Devices Image Figure 6. Global Pain Management Drugs & Devices Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pain Management Drugs & Devices Market Size Share 2021 VS 2025 VS 2032 Figure 8. Cancer Pain Image Figure 9. Obstetrical Pain Image Figure 10. Musculoskeletal Pain Image Figure 11. Migraine Headache Pain Image Figure 12. Burn Pain Image Figure 13. Neuropathic Pain Image Figure 14. Dental/Facial Pain Image Figure 15. Global Pain Management Drugs & Devices Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Figure 17. Global Pain Management Drugs & Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Pain Management Drugs & Devices Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Pain Management Drugs & Devices Revenue Market Share by Region (2021-2032) Figure 20. Global Pain Management Drugs & Devices Sales (2021-2032) & (W Units) Figure 21. Global Pain Management Drugs & Devices Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 22. Global Pain Management Drugs & Devices Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Pain Management Drugs & Devices Sales YoY (2021-2032) & (W Units) Figure 24. Europe Pain Management Drugs & Devices Sales YoY (2021-2032) & (W Units) Figure 25. China Pain Management Drugs & Devices Sales YoY (2021-2032) & (W Units) Figure 26. Asia (Excluding China) Pain Management Drugs & Devices Sales YoY (2021-2032) & (W Units) Figure 27. South America, Middle East and Africa Pain Management Drugs & Devices Sales YoY (2021-2032) & (W Units) Figure 28. Global Pain Management Drugs & Devices Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Pain Management Drugs & Devices Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Pain Management Drugs & Devices Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Pain Management Drugs & Devices Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Pain Management Drugs & Devices Revenue Market Share by Type (2021-2032) Figure 34. Global Pain Management Drugs & Devices Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 35. Global Pain Management Drugs & Devices Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Pain Management Drugs & Devices Sales Market Share by Type (2021-2032) Figure 37. Global Pain Management Drugs & Devices Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Pain Management Drugs & Devices Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Pain Management Drugs & Devices Revenue Market Share by Application (2021-2032) Figure 40. Global Pain Management Drugs & Devices Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 41. Global Pain Management Drugs & Devices Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Pain Management Drugs & Devices Sales Market Share by Application (2021-2032) Figure 43. North America Pain Management Drugs & Devices Revenue Share by Type (2021-2032) Figure 44. North America Pain Management Drugs & Devices Sales Share by Type (2021-2032) Figure 45. North America Pain Management Drugs & Devices Revenue Share by Application (2021-2032) Figure 46. North America Pain Management Drugs & Devices Sales Share by Application (2021-2032) Figure 47. North America Pain Management Drugs & Devices Revenue Share by Country (2021-2032) Figure 48. North America Pain Management Drugs & Devices Sales Share by Country (2021-2032) Figure 49. Europe Pain Management Drugs & Devices Revenue Share by Type (2021-2032) Figure 50. Europe Pain Management Drugs & Devices Sales Share by Type (2021-2032) Figure 51. Europe Pain Management Drugs & Devices Revenue Share by Application (2021-2032) Figure 52. Europe Pain Management Drugs & Devices Sales Share by Application (2021-2032) Figure 53. Europe Pain Management Drugs & Devices Revenue Share by Country (2021-2032) Figure 54. Europe Pain Management Drugs & Devices Sales Share by Country (2021-2032) Figure 55. China Pain Management Drugs & Devices Revenue Share by Type (2021-2032) Figure 56. China Pain Management Drugs & Devices Sales Share by Type (2021-2032) Figure 57. China Pain Management Drugs & Devices Revenue Share by Application (2021-2032) Figure 58. China Pain Management Drugs & Devices Sales Share by Application (2021-2032) Figure 59. Asia Pain Management Drugs & Devices Revenue Share by Type (2021-2032) Figure 60. Asia Pain Management Drugs & Devices Sales Share by Type (2021-2032) Figure 61. Asia Pain Management Drugs & Devices Revenue Share by Application (2021-2032) Figure 62. Asia Pain Management Drugs & Devices Sales Share by Application (2021-2032) Figure 63. Asia Pain Management Drugs & Devices Revenue Share by Country (2021-2032) Figure 64. Asia Pain Management Drugs & Devices Sales Share by Country (2021-2032) Figure 65. SAMEA Pain Management Drugs & Devices Revenue Share by Type (2021-2032) Figure 66. SAMEA Pain Management Drugs & Devices Sales Share by Type (2021-2032) Figure 67. SAMEA Pain Management Drugs & Devices Revenue Share by Application (2021-2032) Figure 68. SAMEA Pain Management Drugs & Devices Sales Share by Application (2021-2032) Figure 69. SAMEA Pain Management Drugs & Devices Revenue Share by Country (2021-2032) Figure 70. SAMEA Pain Management Drugs & Devices Sales Share by Country (2021-2032) Figure 71. Pain Management Drugs & Devices Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Pain Management Drugs & Devices Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmaceuticals
  • Devices
Applications
  • Cancer Pain
  • Obstetrical Pain
  • Musculoskeletal Pain
  • Migraine Headache Pain
  • Burn Pain
  • Neuropathic Pain
  • Dental/Facial Pain
Companies covered
  • Abbott
  • Johnson & Johnson
  • Medtronic Inc.
  • Eli Lilly & Co.
  • Pfizer
  • Abbvie Inc.
  • Purdue Pharmaceuticals Lp
  • Novartis International Ag
  • Hisamitsu Pharmaceutical Co. Inc.
  • Glaxosmithkline
  • Endo International
  • Djo Global Inc.
  • Astrazeneca Depomed Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pain Management Drugs & Devices Market by Type
  3. 1.2.1 Global Pain Management Drugs & Devices Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Pharmaceuticals
  5. 1.2.3 Devices
  6. 1.3 Pain Management Drugs & Devices Market by Application
  7. 1.3.1 Global Pain Management Drugs & Devices Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Cancer Pain
  9. 1.3.3 Obstetrical Pain
  10. 1.3.4 Musculoskeletal Pain
  11. 1.3.5 Migraine Headache Pain
  12. 1.3.6 Burn Pain
  13. 1.3.7 Neuropathic Pain
  14. 1.3.8 Dental/Facial Pain
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Pain Management Drugs & Devices Market Dynamics
  1. 2.1 Pain Management Drugs & Devices Industry Trends
  2. 2.2 Pain Management Drugs & Devices Industry Drivers
  3. 2.3 Pain Management Drugs & Devices Industry Opportunities and Challenges
  4. 2.4 Pain Management Drugs & Devices Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pain Management Drugs & Devices Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pain Management Drugs & Devices Revenue by Region
  3. 3.2.1 Global Pain Management Drugs & Devices Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pain Management Drugs & Devices Revenue by Region (2021-2026)
  5. 3.2.3 Global Pain Management Drugs & Devices Revenue by Region (2027-2032)
  6. 3.2.4 Global Pain Management Drugs & Devices Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pain Management Drugs & Devices Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pain Management Drugs & Devices Sales by Region
  9. 3.4.1 Global Pain Management Drugs & Devices Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pain Management Drugs & Devices Sales by Region (2021-2026)
  11. 3.4.3 Global Pain Management Drugs & Devices Sales by Region (2027-2032)
  12. 3.4.4 Global Pain Management Drugs & Devices Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pain Management Drugs & Devices Revenue by Manufacturers
  2. 4.1.1 Global Pain Management Drugs & Devices Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pain Management Drugs & Devices Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pain Management Drugs & Devices Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pain Management Drugs & Devices Sales by Manufacturers
  6. 4.2.1 Global Pain Management Drugs & Devices Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pain Management Drugs & Devices Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pain Management Drugs & Devices Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pain Management Drugs & Devices Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pain Management Drugs & Devices Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pain Management Drugs & Devices Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pain Management Drugs & Devices Manufacturers, Product Type & Application
  13. 4.7 Global Pain Management Drugs & Devices Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pain Management Drugs & Devices Market CR5 and HHI
  16. 4.8.2 2025 Pain Management Drugs & Devices Tier 1, Tier 2, and Tier 3
5 Pain Management Drugs & Devices Market by Type
  1. 5.1 Global Pain Management Drugs & Devices Revenue by Type
  2. 5.1.1 Global Pain Management Drugs & Devices Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pain Management Drugs & Devices Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pain Management Drugs & Devices Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pain Management Drugs & Devices Sales by Type
  6. 5.2.1 Global Pain Management Drugs & Devices Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pain Management Drugs & Devices Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Pain Management Drugs & Devices Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pain Management Drugs & Devices Price by Type
6 Pain Management Drugs & Devices Market by Application
  1. 6.1 Global Pain Management Drugs & Devices Revenue by Application
  2. 6.1.1 Global Pain Management Drugs & Devices Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pain Management Drugs & Devices Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pain Management Drugs & Devices Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pain Management Drugs & Devices Sales by Application
  6. 6.2.1 Global Pain Management Drugs & Devices Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pain Management Drugs & Devices Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Pain Management Drugs & Devices Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pain Management Drugs & Devices Price by Application
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Pain Management Drugs & Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Pain Management Drugs & Devices Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson Pain Management Drugs & Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson Pain Management Drugs & Devices Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 Medtronic Inc.
  14. 7.3.1 Medtronic Inc. Company Information
  15. 7.3.2 Medtronic Inc. Business Overview
  16. 7.3.3 Medtronic Inc. Pain Management Drugs & Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Medtronic Inc. Pain Management Drugs & Devices Product Portfolio
  18. 7.3.5 Medtronic Inc. Recent Developments
  19. 7.4 Eli Lilly & Co.
  20. 7.4.1 Eli Lilly & Co. Company Information
  21. 7.4.2 Eli Lilly & Co. Business Overview
  22. 7.4.3 Eli Lilly & Co. Pain Management Drugs & Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Eli Lilly & Co. Pain Management Drugs & Devices Product Portfolio
  24. 7.4.5 Eli Lilly & Co. Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer Pain Management Drugs & Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Pain Management Drugs & Devices Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 Abbvie Inc.
  32. 7.6.1 Abbvie Inc. Company Information
  33. 7.6.2 Abbvie Inc. Business Overview
  34. 7.6.3 Abbvie Inc. Pain Management Drugs & Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Abbvie Inc. Pain Management Drugs & Devices Product Portfolio
  36. 7.6.5 Abbvie Inc. Recent Developments
  37. 7.7 Purdue Pharmaceuticals Lp
  38. 7.7.1 Purdue Pharmaceuticals Lp Company Information
  39. 7.7.2 Purdue Pharmaceuticals Lp Business Overview
  40. 7.7.3 Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Product Portfolio
  42. 7.7.5 Purdue Pharmaceuticals Lp Recent Developments
  43. 7.8 Novartis International Ag
  44. 7.8.1 Novartis International Ag Company Information
  45. 7.8.2 Novartis International Ag Business Overview
  46. 7.8.3 Novartis International Ag Pain Management Drugs & Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Novartis International Ag Pain Management Drugs & Devices Product Portfolio
  48. 7.8.5 Novartis International Ag Recent Developments
  49. 7.9 Hisamitsu Pharmaceutical Co. Inc.
  50. 7.9.1 Hisamitsu Pharmaceutical Co. Inc. Company Information
  51. 7.9.2 Hisamitsu Pharmaceutical Co. Inc. Business Overview
  52. 7.9.3 Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Product Portfolio
  54. 7.9.5 Hisamitsu Pharmaceutical Co. Inc. Recent Developments
  55. 7.10 Glaxosmithkline
  56. 7.10.1 Glaxosmithkline Company Information
  57. 7.10.2 Glaxosmithkline Business Overview
  58. 7.10.3 Glaxosmithkline Pain Management Drugs & Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Glaxosmithkline Pain Management Drugs & Devices Product Portfolio
  60. 7.10.5 Glaxosmithkline Recent Developments
  61. 7.11 Endo International
  62. 7.11.1 Endo International Company Information
  63. 7.11.2 Endo International Business Overview
  64. 7.11.3 Endo International Pain Management Drugs & Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Endo International Pain Management Drugs & Devices Product Portfolio
  66. 7.11.5 Endo International Recent Developments
  67. 7.12 Djo Global Inc.
  68. 7.12.1 Djo Global Inc. Company Information
  69. 7.12.2 Djo Global Inc. Business Overview
  70. 7.12.3 Djo Global Inc. Pain Management Drugs & Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Djo Global Inc. Pain Management Drugs & Devices Product Portfolio
  72. 7.12.5 Djo Global Inc. Recent Developments
  73. 7.13 Astrazeneca Depomed Inc.
  74. 7.13.1 Astrazeneca Depomed Inc. Company Information
  75. 7.13.2 Astrazeneca Depomed Inc. Business Overview
  76. 7.13.3 Astrazeneca Depomed Inc. Pain Management Drugs & Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Astrazeneca Depomed Inc. Pain Management Drugs & Devices Product Portfolio
  78. 7.13.5 Astrazeneca Depomed Inc. Recent Developments
8 North America
  1. 8.1 North America Pain Management Drugs & Devices Market Size by Type
  2. 8.1.1 North America Pain Management Drugs & Devices Revenue by Type (2021-2032)
  3. 8.1.2 North America Pain Management Drugs & Devices Sales by Type (2021-2032)
  4. 8.1.3 North America Pain Management Drugs & Devices Price by Type (2021-2032)
  5. 8.2 North America Pain Management Drugs & Devices Market Size by Application
  6. 8.2.1 North America Pain Management Drugs & Devices Revenue by Application (2021-2032)
  7. 8.2.2 North America Pain Management Drugs & Devices Sales by Application (2021-2032)
  8. 8.2.3 North America Pain Management Drugs & Devices Price by Application (2021-2032)
  9. 8.3 North America Pain Management Drugs & Devices Market Size by Country
  10. 8.3.1 North America Pain Management Drugs & Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pain Management Drugs & Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pain Management Drugs & Devices Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pain Management Drugs & Devices Market Size by Type
  2. 9.1.1 Europe Pain Management Drugs & Devices Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pain Management Drugs & Devices Sales by Type (2021-2032)
  4. 9.1.3 Europe Pain Management Drugs & Devices Price by Type (2021-2032)
  5. 9.2 Europe Pain Management Drugs & Devices Market Size by Application
  6. 9.2.1 Europe Pain Management Drugs & Devices Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pain Management Drugs & Devices Sales by Application (2021-2032)
  8. 9.2.3 Europe Pain Management Drugs & Devices Price by Application (2021-2032)
  9. 9.3 Europe Pain Management Drugs & Devices Market Size by Country
  10. 9.3.1 Europe Pain Management Drugs & Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pain Management Drugs & Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pain Management Drugs & Devices Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pain Management Drugs & Devices Market Size by Type
  2. 10.1.1 China Pain Management Drugs & Devices Revenue by Type (2021-2032)
  3. 10.1.2 China Pain Management Drugs & Devices Sales by Type (2021-2032)
  4. 10.1.3 China Pain Management Drugs & Devices Price by Type (2021-2032)
  5. 10.2 China Pain Management Drugs & Devices Market Size by Application
  6. 10.2.1 China Pain Management Drugs & Devices Revenue by Application (2021-2032)
  7. 10.2.2 China Pain Management Drugs & Devices Sales by Application (2021-2032)
  8. 10.2.3 China Pain Management Drugs & Devices Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pain Management Drugs & Devices Market Size by Type
  2. 11.1.1 Asia Pain Management Drugs & Devices Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pain Management Drugs & Devices Sales by Type (2021-2032)
  4. 11.1.3 Asia Pain Management Drugs & Devices Price by Type (2021-2032)
  5. 11.2 Asia Pain Management Drugs & Devices Market Size by Application
  6. 11.2.1 Asia Pain Management Drugs & Devices Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pain Management Drugs & Devices Sales by Application (2021-2032)
  8. 11.2.3 Asia Pain Management Drugs & Devices Price by Application (2021-2032)
  9. 11.3 Asia Pain Management Drugs & Devices Market Size by Country
  10. 11.3.1 Asia Pain Management Drugs & Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pain Management Drugs & Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pain Management Drugs & Devices Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pain Management Drugs & Devices Market Size by Type
  2. 12.1.1 SAMEA Pain Management Drugs & Devices Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pain Management Drugs & Devices Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pain Management Drugs & Devices Price by Type (2021-2032)
  5. 12.2 SAMEA Pain Management Drugs & Devices Market Size by Application
  6. 12.2.1 SAMEA Pain Management Drugs & Devices Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pain Management Drugs & Devices Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pain Management Drugs & Devices Price by Application (2021-2032)
  9. 12.3 SAMEA Pain Management Drugs & Devices Market Size by Country
  10. 12.3.1 SAMEA Pain Management Drugs & Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pain Management Drugs & Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pain Management Drugs & Devices Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pain Management Drugs & Devices Value Chain Analysis
  2. 13.1.1 Pain Management Drugs & Devices Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pain Management Drugs & Devices Production Mode & Process
  6. 13.2 Pain Management Drugs & Devices Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pain Management Drugs & Devices Distributors
  9. 13.2.3 Pain Management Drugs & Devices Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst